Daratumumab-a novel treatment strategy in relapsed/refractory acute leukemia. Borah P, Dayal N, Pathak S, Naithani R, et al. Ann Hematol 2023 Aug 9. doi: 10.1007/s00277-023-05404.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Borah P, Dayal N, Pathak S, Naithani R, et al. Daratumumab-a novel treatment strategy in relapsed/refractory acute leukemia. Ann Hematol 2023 Aug 9. doi: 10.1007/s00277-023-05404.
PMID: 37558803